BioSig receives Nasdaq bid price deficiency; 180-day cure period granted

Streamex Corp.

Nasdaq notified BioSig that bid price was below $1 from June 11 to Oct 23, 2024 failing continued listing requirement.
Company has 180 calendar days to regain compliance by closing bid price >= $1 for 10 consecutive business days.
If not cured, BioSig may qualify for a second 180-day period by meeting other listing standards and intending to reverse split.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.